Related Experiment Video
Updated: Jun 5, 2026

13:08
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Functional Characterization of a Novel Intronic Complement Factor I Variant in Factor I Deficiency and Atypical
Simon Péter Nagy1, Sarolta Dobner2, Fanni Szumutku2
1Research Laboratory, Department of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary.
Kidney International Reports
|June 4, 2026
Summary
A novel intronic variant in the complement factor I (CFI) gene, c.328+42G>A, causes Factor I (FI) deficiency by aberrant splicing. This variant may contribute to atypical hemolytic uremic syndrome (aHUS) in heterozygotes.
Area of Science:
- Genetics
- Complement System Biology
Background:
- Noncanonical intronic splice site variants are implicated in atypical hemolytic uremic syndrome (aHUS).
- A previously identified intronic variant (c.328+42G>A) in the complement factor I (CFI) gene was found in a patient with Factor I (FI) deficiency.
Purpose of the Study:
- Identify additional carriers of the c.328+42G>A CFI variant.
- Functionally characterize the variant's impact on FI expression and its role in aHUS.
Main Methods:
- Screened a genetic registry for potential FI-driven pathologies.
- Conducted complement profiling and genetic analysis on carriers and family members.
- Utilized monocyte-derived dendritic cells (mo-DCs) and real-time PCR to investigate mRNA isoforms and nonsense-mediated decay (NMD).
Main Results:
- Identified 3 additional carriers, showing enrichment in the aHUS cohort.
- All carriers displayed significantly reduced FI levels.
- The variant induced aberrant splicing, producing a truncated FI transcript targeted by NMD, leading to near-complete FI loss.
Conclusions:
- The CFI c.328+42G>A variant causes FI deficiency through aberrant splicing and NMD.
- This variant may predispose individuals to aHUS, particularly in heterozygotes.
- Intronic region analysis is crucial for diagnosing complement-mediated diseases with unknown genetic causes.
Keywords:
atypical hemolytic uremic syndrome (aHUS)complement factor I (FI)complement-mediated thrombotic microangiopathy (CM-TMA)intronic variantMore Related Videos
Related Concept Videos
Protein Complexes with Interchangeable Parts
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Types of Intermediate Filaments
The intermediate filaments are an essential component of the cytoskeleton. Presently six types of intermediate filament have been identified. Type I and II are acidic and basic keratin proteins. Type III is of mesodermal origin and comprises four proteins: vimentin, desmin, glial fibrillary acidic protein (GFAP), and peripherin. Vimentin is commonly found in mesenchymal cells, desmin in muscle cells, GFAP in astrocytes, while peripherin is found in peripheral nervous system neurons (PNS). Type...
Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Multiple Allele Traits
The Concept of Multiple Allelism
Complement System
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...

